← Companies|Scribe Ther
Sc

Scribe Ther

Alameda CAFounded 201860 employees
Private CapbiotechPrivateGenetic Medicine
Platform: X-Editing
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
SCR-7300SCR-7300NDA/BLA2siRNACGRPPI3KiCLL
RimacageneSCR-9365Preclinical2ERTBCL-2SHP2iEoEThymoma
SCR-9075SCR-9075NDA/BLA1ERTPLK4KRASG12DiObesity
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)
2025-09-08
SCR-9075 Ph3 Readout
Obesity
Past
2025-11-03
Rimacagene Interim
Thymoma
Past
2026-11-03
SCR-7300 Ph3 Readout
CLL
Ph3 Readout
2029-07-01
SCR-7300 Ph3 Readout
CLL
Ph3 Readout